The recombinome of IKZF1 deletions in B-cell precursor ALL

Affiliations

• ¹ Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil. blopes@inca.gov.br.
• ² DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany. blopes@inca.gov.br.
• ³ DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany.
• ⁴ Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
• ⁵ Molecular Diagnostics, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, Australia.
• ⁶ Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.
• ⁷ Sydney Children's Hospital, Randwick, NSW, Australia.
• ⁸ Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
• ⁹ Arthur Siqueira Cavalcanti Hematology Institute (HEMORIO), Rio de Janeiro, Brazil.
• ¹⁰ Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil.
• ¹¹ Hospital Amaral Carvalho, São Paulo, Brazil.
• ¹² Prontobaby Hospital da Criança, Rio de Janeiro, Brazil.
• ¹³ Serviço de Hematologia, Hospital do Câncer I, INCA, Rio de Janeiro, Brazil.
• ¹⁴ Hospital Israelita Albert Einstein, São Paulo, Brazil.
• ¹⁵ Medical Genetics, School of Medicine and Surgery, University of Milan Bicocca, Monza, Italy.
• ¹⁶ Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil. memerenciano@inca.gov.br.